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ABSTRACT
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1Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK; 2Cardiovascular and Inflammation Biology, Comparative Biomedical Sciences,
Royal Veterinary College, London, UK; 3Haemostasis Research Unit, Research Department of Haematology, University College London, London, UK; 4Institute of
Inflammation and Ageing, College of Medical and Dental Sciences, Birmingham University, Birmingham, UK; 5Department of Biological and Medical Sciences,
Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK
The UK Extracellular Vesicles (UKEV) Forum meetings were born of the realization that there were a number of UK laboratories studying
extracellular vesicle biology and using similar techniques but without a regular national meeting dedicated to EVs at which to share their
findings. This was compounded by the fact that many of these labs were working in different fields and thus networking and sharing of ideas and
best practice was sometimes difficult. The first workshop was organized in 2013 by Dr Charlotte Lawson, under the auspices of the Society for
Endocrinology, led to the founding of the UKEV Forum and the organization of a British Heart Foundation sponsored 1-day conference held in
London in December 2014. Although growing in size every year, the central aims of these workshops have remained the same: to provide a
forum for discussion and exchange of ideas, to allow young scientists to present their data in the form of short talks and poster presentations and
to discuss their work with more established scientists in the field. Here we include the presented abstracts for the 2015 1-day conference hosted
by Cardiff University. This meeting was attended by approximately 130 delegates throughout the United Kingdom, but also attended by
delegates from Belgium, Netherlands, France, Ireland and other nations. The day composed of plenary presentations from Prof Matthias Belting,
Lund University, Sweden and Dr Guillaume van Niel, Institut Curie, Paris together with 10 short presentations from submitted abstracts. The
topics covered were broad, with sessions on Mechanisms of EV production, EVs in Infection, EVs in Cancer and in Blood and Characterizing EVs in
Biological fluids. This hopefully gives a reflection of the range of EV-related studies being conducted currently in the UK. There were also 33
poster presentations equally broad in subject matter. The organizers are grateful to the Life Science Research Network Wales  a Welsh
government-funding scheme that part-sponsored the conference. We are also grateful to commercial sponsors, and 3 paid-presentations are
included in the abstracts. The UK EV Forum is expected to become an established annual event held at different Universities across the UK and
continue to attract increasing delegate numbers and abstract submissions. We look forward to the next planned conference, which will be hosted
by David Carter and his colleagues at Oxford Brookes University on 13th December 2016.
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Short Talk 1
Extrusion of inside-out, phosphatidylserine-exposed, autophagic
vesicles in the formation of human erythrocytes
Tosti J. Mankelow*, Rebecca E. Griffiths* and David J. Anstee
Bristol Institute for Transfusion Sciences, NHS Blood and Transplant,
Filton, Bristol, UK
*These authors have been equally contributed to the work.
Background: During maturation to an erythrocyte, a reticulocyte must
eliminate any residual organelles and reduce its surface area. We have
shown that both are achieved through a novel form of exocytosis
whereby large (1.4 mm) intact, inside-out phosphatidylserine-
exposed vesicles are expelled from the maturing reticulocyte (1,2).
The exposed ‘‘eat me’’ phosphatidylserine signal ensures that
released autophagic vesicles are rapidly removed from circulation
by professional phagocytic cells within the spleen. Asplenic patients
(by surgery or the pathological processes of haemoglobinopathies
such as sickle cell disease) show elevated levels of circulating PS
positive red cells as a result of inefficient release of these autophagic
vesicles from their surface (2). Methods: Confocal microscopy was
used to analyse the cellular location of proteins in reticulocytes
produced from an in vitro culture system described in (1). Results:
In reticulocytes, the autophagic vesicles contain organelle marker
proteins and numerous erythroid membrane proteins, notably CD71
(Transferrin receptor), CD147 (Basigin) and stomatin. The presence of
ubiquitin suggests a recognized mechanism for the targeting of
proteins for extracellular export or degradation. Myosin motors are
used to traffic autophagic vesicles around the maturing reticulocyte
whereas other proteins involved in vesicle trafficking, SNARE (VAMP7)
and ESCRT (CHMP4B), locate to defined positions at the point of
vesicle extrusion. Conclusions: Our results show that autophagic
vesicle release by maturing reticulocytes is a cellular process that
although initiated and directed by the cell is facilitated by passage
through the spleen. Their release ensures that the maturation, into
erythrocytes, of the 2 million reticulocytes that the human body
produces every second (3) occurs without the systemic release
of potentially toxic material. Together our results describe a
previously unrecognized mode of exocytosis which may have signifi-
cance beyond erythropoiesis particularly with respect to apoptosis and
autophagy.
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Short Talk 2
Role of purinergic signalling in regulation of unconventional
protein secretion
Rhiannon Griffiths, Magdalena Adamczyk, Sharon Dewitt Parr and
Daniel Aeshlimann
School of Dentistry, Cardiff University, Cardiff, UK
Background: Transglutaminase 2 (TG2) is an early response gene
with an extracellular function in tissue repair. It is secreted via an
unconventional and enigmatic pathway. Microvesicle release and
the exosome pathway have been implicated. Our group has shown
that active TG2 export is controlled by purinergic signalling, and
implicated P2X7 receptor activation. P2X7R has several activation
states; ATP stimulation causes ion channel opening, allowing
membrane depolarization and Ca2 entry into the cell. Prolonged
stimulation leads to ‘‘large membrane pore’’ activity; however, the
identity of this pore is unknown and as there is conflicting evidence
suggesting either dilation of the P2X7R channel itself or an interaction
with an alternative plasma membrane channel. P2X7R activation can
lead to extensive changes to membrane structure, potentially leading
to vesicle shedding. We investigate how cells export TG2 and control
its activation, potentially identifying a novel secretory pathway used
by select proteins, including potent signals regulating inflammation.
Objective: We aim to elucidate mechanistically the process by which
cells export TG2 and control its activation. Methods: P2X7R variants
were stably expressed in HEK293 cells. P2X7R pore formation was
assessed using YO-PRO1 uptake by cells. TG2 externalization was
assessed by western blotting of conditioned medium. Differential
centrifugation and sucrose density gradients were used to assess the
presence of TG2 in vesicles by western blotting. Myeloid precursors
were isolated from human blood and differentiated using GM-CSF.
Results: P2X7R activation induced membrane bleb formation and MV
shedding. Pharmacological suppression of P2X7R ion channel func-
tion without affecting membrane pore formation, abrogated forma-
tion of flotillin-2 containing MV but not TG2 export. Separation
of MV and analysis of associated proteins confirmed the absence of
TG2. In contrast, introducing a gain-of-function mutation in P2X7R,
that enhanced pore activity, resulted in accelerated TG2 export. To
confirm the transferability of our findings to innate immune cells,
human peripheral blood monocytes were differentiated into M1
macrophages and P2X7R mediated TG2 export was confirmed
and was independent of inflammasome formation. Discussion: We
show that P2X7R activation triggers shedding of specific MV.
Unexpectedly, TG2 export was MV independent but linked to
thioredoxin-1 secretion. Furthermore, P2X7R induced membrane
pore activity directly correlated with TG2 export but was not
associated with MV formation. Hence, the respective pathways are
distinct. P2X7R polymorphisms affecting membrane pore formation
may also affect extracellular levels of proteins secreted via this
pathway. This begins to identify components of a mechanism for
unconventional protein secretion crucial to innate immunity.
Short Talk 3
Excluded on request of the authors
Short Talk 4
The pathogenic blood fluke Schistosoma mansoni releases protein and
small non-coding RNA-enriched extracellular vesicles, which could play
a role in hostparasite interactions during schistosomiasis
Fanny Carole Nowacki1, Martin T. Swain1, Oleg I. Klychnikov2, Umar Niazi1,
Alasdair Ivens3, Juan F. Quintana3, Paul J. Hensbergen2,
Cornelis H. Hokke4, Amy H. Buck3 and Karl F. Hoffmann1
1Animal and Microbial Sciences (AMS), Institute of Biological, Environmental and
Rural Sciences, Aberystwyth University, UK; 2Centre for Proteomics and
Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; 3CIIE,
University of Edinburgh, Edinburgh, UK; 4Department of Parasitology, Leiden
University Medical Center, Leiden, The Netherlands
Background: Upon skin penetration, larval blood fluke schistosomes
(schistosomula) release excretory/secretory (E/S) products in an
attempt to establish and maintain infection in mammalian hosts.
Previous studies have postulated functions for these E/S products in
initiating crucial host-modulatory events. However, the role of
extracellular vesicles (EVs) has yet to be investigated. Here, we
conducted the first characterization of Schistosoma mansoni schis-
tosomula EVs and their potential host-regulatory cargos. Methods:
After cultivating schistosomula for 72 h in culture medium lacking
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foetal calf serum, E/S products were harvested using preparatory
ultracentrifugation. Collected EVs were analysed by transmission
electron microscopy (TEM) and liquid chromatography tandem
mass spectrometry proteomics (LCMS/MS) and both EV-enriched
as well as EV-depleted fractions were subjected to Illumina next
generation sequencing (NGS) of small-noncoding RNA (sncRNA)
libraries. Results: TEM analysis revealed the presence of numerous
exosome-like EVs, the first observation for S. mansoni. The proteomic
analysis of these vesicle cargos revealed a set of 109 proteins,
including homologues of proteins found enriched in other eukar-
yotic EVs and highly abundant non-conserved proteins of unknown
function. The characterization of potentially gene regulatory E/S
sncRNA population within and outside of EVs revealed the presence
of tRNA-derived small RNAs (tsRNAs: nineteen 5’ and fourteen 3’
tsRNAs; using an in-house script) and microRNAs (miRNAs: 35 known
and 170 platyhelminth novel miRNAs found using miRDeep2
and miRBase). In silico target prediction of these miRNAs (analysed
by 4 different software packages: miRanda, microTar, RNAhybrid
and PITA) identified thousands of putative mRNA targets, which
supports their gene regulatory potential within both mammalian
and schistosome biology. Conclusion: The discovery of schistosome
EVs and the characterization of their protein and sncRNA compo-
nents identify a new participant in the complex biology under-
pinning schistosome/host interactions. Further work is ongoing to
define the role of schistosomula EVs and the functional significance
of the biological components (e.g. proteins, sncRNAs) found
within EV-enriched and EV-depleted E/S fractions. These findings
open up the way for developing novel schistosomiasis diagnostics or
interventions.
Short Talk 5
Expression of Molluscum contagiosum virus gene mc162 leads
to extracellular vesicle formation
Joachim Jakob Bugert1,5, Iona Ashworth1, Hana Elasifer1,
Tom Hickin1, Megan Wadon1, Laura Farleigh2, Asif Nizam3
and Nadja Melquiot4
1Department of Medical Microbiology and Infectious Diseases Cardiff
University, Cardiff, UK; 2Wellcome Trust-MRC Institute of Metabolic Science
Cambridge University, Cambridge, UK; 3Department of Microbiology, Dhaka
University, Dhaka, Bangladesh; 4Channing Laboratory, Brigham & Women’s
Hospital, Boston, MA, USA; 5Institut fu¨r Mikrobiologie der Bundeswehr,
Neuherbergstr. 11, D-80937 Mu¨nchen, Germany
Background: Molluscum contagiosum Virus (MCV) is a human pox-
virus causing benign epidermal tumours in children and immu-
nosuppressed individuals. The early MCV type 1 membrane protein
mc162 contains 2 proline rich motifs (P5Y and P3Y) and a dileucine
motif in its c-terminal cytoplasmatic domain. Methods: Human HaCaT
keratinocyte extracts were probed with mc162GST fusion proteins
and tested for coprecipitating proteins by MS and targeted western
blot. A pIRESneo plasmid construct (p20) and a recombinant vaccinia
virus expressing mc162-flag as a GFP-fusion protein (v354) were used
to establish membrane domain patterns in infected cells. Lentiviral
constructs with a tet regulated promoter (tetON) expressing mc162-
flag were established to minimize gene toxicity (pHAGE/tetON;
p496/502). Results: The c-terminal 110 amino acid residues of mc162
bind E3 protein-ubiquitin ligases AIP4 and Nedd4 and the hepato-
cyte growth factor tyrosine kinase substrate (Hgs/Hrs) derived from
human HaCaT keratinocytes. Cells over-expressing mc162 acquire an
aberrant early endosomal vesicle phenotype similar to Hrs negative
mouse fibroblasts derived from Hrs/ knockout mice, which is
toxic for cells, preventing stable transfection of cell lines and
generation of admc162. In v354 infected cells we have observed
extrusion of extracellular DAPI negative vesicles carrying mc162 and
AIP4. Conclusions: Involvement of PY motif carrying proteins in virus
budding has been described (1). Possible roles of mc162 in surface
receptor regulation, setting up of viral factories and the vegetative
spread in human epidermis are discussed. We currently use a
lentiviral expression system to further study the connection between
mc162 expression and release of extracellular vesicles.
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Short Talk 6
The role for platelet-derived extracellular vesicles in recruiting
neutrophils to vascular endothelium during inflammation
Sahithi Jyothsna Kuravi, George Ed Rainger and Gerard B. Nash
Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
Background: Platelet extracellular vesicles (PEV) account for a
large proportion of circulating extracellular vesicles and have
been suggested to promote leukocyte recruitment to the vascular
endothelium. The rate of PEV binding to endothelial cells (EC), their
influence on neutrophil recruitment and mechanisms involved are not
well understood. We aimed to determine the binding kinetics of PEV to
EC and the resultant effects on neutrophil recruitment from flow.
Methods: PEV were generated from CD41-labelled platelets, stimu-
lated with collagen related peptide (CRP-XL, 1 mg/ml) and were
incubated with EC. PEV-mediated stimulation of EC was assessed by
flow cytometry for adhesion receptors. Flow-based adhesion assay
assessed neutrophil recruitment on PEV-coated on glass capillaries or
on EC grown in flow chambers and treated with combinations of PEV
and different concentrations of TNF-a. Blocking studies were per-
formed to assess the role for chemokine receptors. Chemokines in
cell supernatants were measured using multiplex chemokine array.
Results: PEV binding to EC was detected within 1 h and maximal by 4 h
with 60% dual positivity for CD41 and VE-cadherin on EC. The PEV
uptake resulted in upregulation of endothelial activation markers (E-
selectin and VCAM-1). Neutrophils bound directly to PEV enabling
frequent inflow capture and low levels of stable adhesion to a PEV-
coated surface. Similar effects of PEV were observed on unstimulated
or minimally stimulated (1U/ml TNF-a) EC. Blocking studies revealed
roles for P-selectin, platelet activating factor and chemokine receptors
in PEV-mediated neutrophil capture and adhesion. Furthermore, PEV
supernatants contained platelet chemokines such as platelet factor
4 and RANTES along with Interleukin-8, GRO-a, ENA-78 and MCP-1.
Conclusions: Surface-bound PEV can directly capture flowing neutro-
phils and also activate ECs. Thus PEV may promote neutrophil
recruitment in inflammation, by potentiating effects of low levels of
cytokines acting on EC.
Short Talk 7
The modulatory potential of Mesenchymal Stem Cells is
mediated by the release of immunologically active
extracellular vesicles
Monica Sofia Correia dos Reis, Lindsay Nicholson, Emily Mavin, Anne
Dickinson and Xiao-nong Wang
Academic Haematology, ICM, Medical School, Newcastle University, Newcastle
upon Tyne, UK
Background: Mesenchymal Stem Cells (MSCs) are widely used for the
treatment of many diseases due to their differentiation potential
and immunomodulatory capacity. Increasing evidence has shown
that the therapeutic effects of MSCs are a result of their secretome,
which includes paracrine factors and extracellular vesicles (EVs). EVs
are membrane-derived particles that function as mediators of cell
communication via horizontal transfer of functional proteins and
genetic material. In this study we examine the immunosuppressive
potential of BM-MSC-derived EVs by investigating their ability to
modulate allogeneic T cell responses. Methods: MSCs were isolated
from BM aspirates from healthy donors and characterized as per the
ISCT criteria. EVs were isolated by ultracentrifugation and character-
ized by protein quantification, nanoparticle tracking analyses (NTA),
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transmission electron microscopy and flow cytometry. For functional
characterization, titrated doses of EVs were added to mixed leukocyte
reaction containing 1105 responder T cells and 1104 monocyte-
derived dendritic cells (moDCs) and proliferation was assessed by
3H-thymidine incorporation. EV uptake was assessed by EV labelling
with membrane-dye PKH26 and detected using immunofluores-
cence microscopy and flow cytometry. The effect of inhibition of
EV secretion by MSCs on T cell proliferation was performed by pre-
treating MSCs with GW4869, following co-culture with PHA stimu-
lated T cells. Results: Sufficient amount of MSC-derived EVs were
successfully collected from approximately 5107 MSCs. Flow
cytometry analyses of EV markers showed enrichment in CD63, CD9
and CD81. TEM exhibited characteristic cup-shaped morphology of
EVs. In vitro experiments showed a dose-dependent capacity of MSC-
EVs to inhibit T cell proliferation with 30% inhibition at highest EV
dose. Inhibition of EV secretion by MSCs indicated an abrogation
of MSC capacity to inhibit T cell proliferation, showing a 3-fold
increase in proliferation of T cells in the co-cultures with GW4869
pre-treated MSCs when compared to the DMSO-vehicle control.
Immunofluorescence detection of MSC-EVs internalization by target
cells showed a preferential association of EVs with monocyte-derived
DCs and a small subset of CD3 T cells. Further analysis of EV uptake by
flow cytometry, showed a dose-dependent increase in EV internalization
by CD3 T cells, with a preferential uptake by CD4 T cells, with
11.3% PKH26 cells in comparison with 6.1% of CD8PKH26 T
cells. Conclusions: Our results show that MSC-derived EVs are immuno-
logically active structures that have the ability to suppress allogeneic T
cell responses. Further studies are ongoing to elucidate the mechanism
by which MSC-EVs modulate DC and T cell functions.
Short Talk 8
The human pericardial fluid is enriched with exosomal microRNAs of
cardiac origin that show a therapeutic potential
Cristina Beltrami, Saran Shantikumar, Marie Besnier, Andrew Shearn, Cha
Rajakaruna, Gianni D. Angelini and Costanza Emanueli
Bristol Royal Infirmary, University of Bristol, Bristol, UK
Background: Cells release functionally active microRNAs (miRs) into
extracellular vesicles (EVs) as intercellular communication. The
functional relevance of EVs in the context of human physiopathology
is still debated. We hypothesize that the pericardial fluid (PF)
mediates myocardium cell-to-cell communication through exchange
of exosomes. We aimed to (a) characterize the PF miRs and
exosomes content; (b) investigate the biological function of PF
exosomes. PF, plasma, thoracic aorta (TA) and right atrium appen-
dage (RAA) samples were collected as leftover material from aortic
valve replacement surgery. The top expressed cardiovascular miRs in
the PF were identified by miRs-array and then validated by RTqPCR
in TA and RAA, PF and plasma, and in exosomes from PF or plasma.
Methods: Exosomes were studied by nanoparticle tracking analysis
(NTA) and transmission electron microscopy (TEM). The angiogenic
capability of PF and plasma exosomes was investigated in hypoxic
human endothelial cells (ECs) and in a mouse model of limb
ischaemia (LI). The contribution of miRs to the functional properties
of exosomes was assessed in EC with reduced miR biogenesis after
knockdown (KD) of DICER (enzyme responsible for the final step of
miR maturation), followed by PF exosomes treatment. Additionally,
the pro-angiogenic role of let-7b-5p (an miR that was highly
expressed in PF exosomes and it is known to be pro-angiogenic)
was investigated by comparing the effect induced by either
PF-derived exosomes or PF-derived exosomes depleted of let-7b-
5p on ECs with Dicer KD. Results: A pool of cardiovascular miRs was
expressed in patients’ TA and RAA and enriched in the PF vs plasma,
suggesting the cardiac and vascular origin of these PF miRs. As
expected, miR-122 that is not expressed in cardiovascular cells was
undetectable in the PF. Exosomes were present in the PF. In vitro PF-
exosome treatment of hypoxic ECs decreased cells apoptosis,
increased cell proliferation and tube formation. The pro-angiogenic
effect of PF-derived exosomes is partially miRs dependent. We found
that PF exo-miR, let-7b-5p, contributes to restore angiogenesis
in DICER-depleted ECs. Local delivery of PF exosomes increased
post-ischaemic blood flow recovery and reparative angiogenesis,
while plasma exosomes were not effective. Conclusions: We have
shown the therapeutic potential of PF exosomes from cardiovascular
patients. Future studies will be tailored to exploit the properties of
PF-exosome in regenerative medicine.
Short Talk 9
Cerebrospinal fluid extracellular vesicles as a source
of biomarkers for multiple sclerosis
Joanne L. Welton1,2, Sam Loveless3, Tim Stone4,
Neil P. Robertson3 and Aled Clayton1
1Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK;
2Biomedical Sciences, Cardiff School of Health Sciences, Cardiff Metropolitan
University, Cardiff, UK; 3Institute of Psychological Medicine and Clinical
Neurosciences, School of Medicine, Cardiff University, Cardiff, UK;
4Central Biotechnology Services, Cardiff University, Cardiff, UK
Background: Multiple sclerosis (MS) is one of the most common
neurological disorders in young adults affecting over 100,000 people
in the UK, with 5,000 new cases diagnosed each year. There are
currently no widely available reliable biomarkers to aid in, the often
lengthy, diagnosis or monitoring of the disease. In this pilot study we
develop methods of isolation and proteomic analysis to examine the
potential use of extracellular vesicles (EVs), in particular exosomes, as a
novel source of biomarkers for the relapsing remitting form of multiple
sclerosis. Methods: A workflow was developed for the isolation of EVs
from cerebrospinal fluid (CSF), using a combination of precipitation
and size exclusion chromatography (SEC) (Exo-spinTM; Cell Guidance
Systems). The EV-enriched fractions were selected based on char-
acteristics including increase in EV-associated tetraspanins using an
ELISA-like assay and particle-to-protein ratio (NanoSightTM and Nano-
DropTM). EVs were isolated from pooled relapsing remitting-MS patient
(RRMS) (n4) and control (n3) cell-free CSF. These EVs along with
their paired cell-free CSF were subsequently analysed using a novel
aptamer-based protein array assay (SOMAscanTM), providing relative
levels for each of 1,128 proteins. Results: The use of precipitation
and SEC allowed for the selection and pooling of EV-enriched fractions
and the removal of 75% of contaminating abundant protein. These
EV isolates were confirmed to be compatible with the SOMAscanTM
platform, even with the potential presence of remaining precipitant
that would otherwise interfere with a mass spectrometry-based
proteomics platforms. Around 350 and 580 proteins out of 1,128 were
identified in CSF-derived exosomes and cell-free CSF respectively, of
which 50 proteins were found significantly and exclusively enriched in
RRMS-derived exosomes. Some of these EV-enriched proteins were
further evaluated and some proteins, such as KLKB1 (Fletcher factor),
were found to be enriched in EVs compared to cell-free CSF, by
western blot. An interactive network based on these 50 proteins
was created using Cytoscape, revealing strong associations with
proteins related to the complement pathway, ionic binding, secreted
proteins and extracellular regions. Conclusions: This study demon-
strates that EVs can be isolated from MS patient CSF and highlights the
potential to identify proteins of possible interest which are specifically
enriched in the concentrated EV fraction. This proof of concept study
shows the potential of CSF EVs as a novel source of biomarkers in
MS and future work will examine EVs in MS in more depth.
Short Talk 10
Lipoprotein-associated phospholipase A2 is released by
the placenta into the maternal circulation via
syncytiotrophoblast extracellular vesicles: a potential
role in pre-eclampsia
Chris Gardiner1, Emily Russell2, Sylvia Shahjahan2, Dionne Tannetta2,
Ian Sargent2 and Manu Vatish2
1Haemostasis Research Unit, University College London, London, UK; 2Nuffield
Department of Obstetrics and Gynaecology, University of Oxford, oxford, UK
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Background: The maternal syndrome of pre-eclampsia is the result of
vascular dysfunction caused by the release of soluble factors (e.g.
endoglin and soluble VEGF receptor[s-flt-1]) and syncytiotrophoblast
extracellular vesicles (STBEV) from the placenta into the maternal
circulation. Lipoprotein-associated phospholipase A2 (Lp-PLA2)
causes endothelial dysfunction via F2-isoprostane (e.g. 8-isoprostane)
formation and lipid peroxidation. As Lp-PLA2 has been reported in
trophoblasts we hypothesized a role for Lp-PLA2 in pre-eclampsia.
Methods: STBEV were prepared by perfusing placentae from 6 normal
pregnant women and 6 with pre-eclampsia. Lp-PLA2 was detected by
immunofluorescence of placental sections and western blotting of
STBEV. In addition, paired peripheral and uterine venous samples
collected from 6 normal pregnant women were analysed for vesicular
placental alkaline phosphatase (PlAP, a protein unique to the
placenta) and malondialdehyde (MDA, a marker of lipid peroxidation).
Results: Lp-PLA2 was demonstrated on syncytiotrophoblast in pla-
cental sections and STBEV from normal and pre-eclamptic women.
PLAP and MDA were significantly higher in blood collected from the
uterine vein (200 v 109 ng/ml and 1.76 v 1.28 mM, respectively) than in
peripheral venous blood, and were positively correlated (r0.51),
indicating an association between placental Lp-PLA2 activity and release
of STBEV. Discussion/conclusion: Lp-PLA2 expression in STBEV, combined
with increased lipid peroxidation in uterine venous blood on PE STBEV,
indicate a potential role for placental Lp-PLA2 in the maternal
endothelial dysfunction which is characteristic of pre-eclampsia.
Sponsored
presentation 1
Combining size exclusion chromatography and tunable resistive pulse
sensing technology for the characterization of extracellular vesicles
Julien Muzard1, Murray Broom2, Stephen Mann2 and
Hans Van Der Voorn1
1Magdalen Centre, The Oxford Science Park, Izon Science, Oxford, United
Kingdom; 2Bionanotechnology, Izon Science, Christchurch, New Zealand
Tuneable Resistive Pulse Sensing (TRPS) is a particle-by-particle
technology that enables measurements of nano-sized particles with
a very high-resolution. TRPS measures individual particle by analysing
the durations, the frequencies and magnitudes of the resistive pulses
under varying driving forces across a pore-based sensor and by using
reference particles calibrated for size, surface charge and concentra-
tion. For the extracellular vesicles (EVs) field, the complete cycle of
sample preparation, measurement and analysis of EVs from blood
plasma using both size exclusion chromatography and TRPS is now by
far the fastest option as well as the most reliable and accurate. In this
communication, I will describe how TRPS offers significant and unique
advantages over laser-based approaches for characterizing EVs
(e.g. size and concentration). Furthermore, our latest developments
on particle-by-particle charge analysis and phenotyping EVs popula-
tion will be outlined and discussed.
Sponsored
presentation 2
Exposure of cancer cells to EGFR-inhibitors changes protein
composition of extracellular vesicles
Susan van Dommelen, Raymond Schiffelers, Roy van der Meel,
Robbert Zuidema, Romy Verschoor and Pieter Vader
Laboratory for Clinical Chemistry and Hematology, University Medical
Center Utrecht, Utrecht, the Netherlands
Background: Tumour cell-derived extracellular vesicles (EVs) reflect
the status of the parental cells. This makes EVs promising candidates
for biomarkers, for example to monitor treatment. In this study, we
exposed tumour cells to cetuximab (a monoclonal antibody that
blocks the activation of epidermal growth factor receptor (EGFR)
and erlotinib (a kinase inhibitor blocking EGFR-signal transduction)
and examined the effect on extracellular vesicle composition.
Methods: We exposed A431 human epidermoid carcinoma cells to
1 mM erlotinib or 100 mg/ml cetuximab. In one set-up we used
ultracentrifugation to isolate extracellular vesicles followed by
western blotting of EGFR and phospho-EGFR (pEGFR) and vesicles
markers Alix, TSG101 and CD9. In another set-up we captured the
extracellular vesicles with magnetic microbeads and isolated them in a
magnetic stand. We used fluorescent antibodies to probe the vesicle
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surface for EGFR, CD147 and tetraspanins and analysed fluorescence
on a flow cytometer. Results: Using the ultracentrifugation set-up, we
could demonstrate that both EGFR and pEGFR on the EVs were
reduced after cetuximab treatment, reflecting similar changes in the
parental cells. Also the expression of the tetraspanin CD9 was reduced.
Using density gradient ultracentrifugation, we could observe that
cetuximab bound to EVs. EV-associated cetuximab retained its activity.
For the magnetic beads conjugated with anti-CD9 antibody we could
capture tumour-derived EVs directly from cell culture medium. Analysis
by flow cytometry showed marked loss of CD147 and EGFR for EVs
form cetuximab treated cells, which was not the case for cells treated
with erlotinib. Discussion: Cetuximab treatment alters the composition
of EVs, reflecting the parental cell status. This indicates that EVs could
serve as biomarkers to monitor cetuximab treatment efficacy.
Sponsored
presentation 3
Whole exosome fluorescent labelling measured with F-NTA
Pauline Carnell-Morris, Patrick Hole, Agnieszka Siupa and Andrew Malloy
Malvern Instruments Ltd, Amesbury, UK
Background: NTA is a common technology for characterizing both size
and number concentration of exosomes. It is often extended to
fluorescence labelling in order to get better insight into the samples
(F-NTA). However, the protocol for carrying out such a measurement
can be challenging because there are multiple variables that are
required to be investigated and optimized. This need not take a long
time if carried out in a methodical approach. Membrane-labelling or
cell-labelling dyes have been suggested as a means to positively
identify exosomes from any contaminants that potential remain in the
sample at the end of sample preparation. Here we review several
proposed membrane-labelling dyes and share our results and advice
on some of the factors that influence the effectiveness of the
measurement. Methods: Three common and commercially available
membrane- or cell-labelling dyes (PKH, DiI and CellMaskTM) were used
to label human-derived exosomes. Titrations of dye: exosomes were
carried out, incubation times were investigated as was the overall
incubation volume in order to optimize labelling conditions. Various
instrument configurations and settings were investigated to ensure
optimum visualization of the sample under measurement. Sample
measurements along with appropriate controls were taken under
both scatter and fluorescence to measure the size distribution and
concentration with NTA and to evaluate labelling efficiency. Results: All
dyes were demonstrated to successfully label exosomes. Various issues
were identified during the optimization process, such as disturbing the
stability of the sample by the addition of dye formulation buffer,
influence of dye preparation understanding the risk of labelling
contaminants that may co-purify with exosomes and interactions with
buffers, for example. For all dyes a constant flow of sample was required
to ensure sufficient particles were included in the results due to the rate
of photobleaching exhibited by the samples and to improve concen-
tration measurements. Conclusions: F-NTA has been demonstrated to
be an effective and rapid way to characterize and identify the presence
of membrane-containing particles. From the dyes tested, we found
CellMaskTM orange to be the easiest reagent to use to label membrane-
containing nanoparticles. The other dyes required more optimization
steps and more complex protocols to label the exosome samples.
Poster 1
Hostparasite interactions: the Leishmania flagellum as
a secretory organelle
Laura Makin and Eva Gluenz
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
Leishmania are protozoan parasites which are transmitted between
mammalian hosts by the Phlebotomine sand fly. The amastigote form
resides in the hostile environment of the phagolysosome of mono-
nuclear phagocytes where it must resist detection and degradation by
the host cell. During differentiation upon entering the mammalian
host the long promastigote flagellum shortens dramatically leaving
only the tip exposed. It is unknown what becomes of the excess
flagellar membrane during this process. To investigate whether
flagellar-derived vesicles could provide a mechanism for delivery
of virulence factors we used differential centrifugation to isolate
vesicles from conditioned medium of Leishmania undergoing differ-
entiation. This resulted in the isolation of vesicles which were further
characterized by electron microscopy, protein western blotting and
mass spectrometry. Putative vesicle-associated proteins and virulence
factors have been identified in the isolated material and research is
ongoing to determine the detailed composition and subcellular origin
of the vesicles.
Poster 2
Urinary microRNAs are stabilized by association with exosomes
and argonaute 2 protein
Kate Simpson1, Cristina Beltrami1, Aled Clayton2, Lucy J. Newbury1,
Robert H. Jenkins1, Aled O. Phillips1, Donald J. Fraser1 and
Timothy Bowen1
1Wales Kidney Unit, College of Biomedical and Life Sciences,
Cardiff University, Cardiff, UK; 2Institute of Cancer & Genetics, School of medicine,
College of Biomedical Life Sciences, Cardiff university, UK
Background: Chronic kidney disease (CKD) has been identified as a
major global clinical problem, but despite extensive study prediction
of injury progression remains elusive. MicroRNAs (miRNAs) have
emerged as novel biomarkers for a variety of diseases. These
transcripts are present in body fluids, and urinary miRNAs are
accessible non-invasively. In this study we investigated the stability
in control human urine samples of the ubiquitously expressed
transcript miR-16, and of miR-192, which we have shown previously
to be down-regulated in renal fibrosis. Methods: RNase A (0.1 mg/ml)
and proteinase K (50 mg/ml) digestions were carried out using 2.5 ml
urine aliquots in which endogenous miRNA expression was com-
pared with spiked-in Caenorhabditis elegans miRNA cel-miR-39.
Following incubation at 37 or 558C, respectively, 250 ml aliquots
were removed at appropriate time points, RNA was isolated, and
then miR-16 and cel-miR-39 were detected by RT-qPCR. Extracellular
vesicles were isolated using density gradient centrifugation proto-
cols that we described previously. RNA-immunoprecipitation was
used to analyse association of urinary miR-16 and miR-192 with
argonaute 2 (AGO2) protein. Results: Endogenous urinary miR-16 was
significantly more resistant to RNase-mediated degradation than
exogenous, spiked-in cel-miR-39. MiR-16 and miR-192 were enriched
in exosomal sucrose gradient fractions, but were also detected in all
other fractions. This suggested association of urinary miRNAs with
other urinary extracellular vesicles and/or pellet components,
complicating previous estimates of miRNA: exosome stoichiometry.
Proteinase K digestion destabilized urinary miR-16 and we showed,
for the first time, RNA-immunoprecipitation of urinary miR-16:AGO2
and miR-192:AGO2 complexes. Conclusions: Association with exo-
somes and AGO2 stabilized urinary miR-16 and miR-192, suggesting
quantitative urinary miRNA analysis has the potential to identify
novel, non-invasive CKD biomarkers.
Poster 3
Evaluation of optimal extracellular vesicle small
RNA isolation and qRT-PCR normalization for serum
and urine samples
Rachel E. Crossland, Jean Norden, Louis Bibby, Joanna Davis and
Anne M. Dickinson
Haematological Sciences, Institute of Cellular Medicine, Newcastle University,
Newcastle upon Tyne, UK
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Background: MicroRNAs are small regulatory molecules that demon-
strate useful biomarker potential. They have recently been recog-
nized in biofluids, where they are protected from degradation by
encapsulation into extracellular vesicles (EVs). A number of commer-
cial products are available for the isolation of EVs and their RNA
content, however, extensive protocol comparisons are lacking.
Furthermore, robust qRT-PCR assessment of microRNA expression
within EVs is problematic, as endogenous controls previously used in
cellular samples may not be present. This study compares EV isolation
and RNA extraction methods (EV precipitation reagents, RNA isolation
kits and ultracentrifugation) from serum or urine samples and
evaluates suitable endogenous controls for incorporation into qRT-
PCR analysis. Methods: Extracellular vesicles and associated RNA was
isolated from serum and urine by comparing commercial precipita-
tion reagents (Life Technologies & System Biosciences (SBI)), ultra-
centrifugation and popular RNA isolation kits (Norgen Biotek (NB)
Total RNA Purification Kit, SBI SeraMirTM Exosome RNA Purification
Column kit, Qiagen miRNeasy Micro kit, Ambion mirVanaTM miRNA
Isolation Kit, Invitrogen Total Exosome RNA & Protein Isolation Kit and
NB Urine Exosome RNA Isolation Kit). Isolated EVs were assessed by
electron microscopy (EM) and nanoparticle tracking analysis (NTA).
Total RNA concentration was assessed using the Bioanalsyzer (RNA
Pico Kit). Small RNA (HY3, RNU48, U6) expression was assessed by
TaqMan qRT-PCR. The stability of 8 endogenous controls (EC) (HY3,
RNU48, miR-320, RNU6B, RNU19, U6, RNU38B and RNU43) was
compared for urine and serum EV RNA (BestKeeper and NormFinder)
and retrospectively validated in independent cohorts (serum n55,
urine n50). Results: The Life Technologies precipitation reagent
gave superior serum EV recovery compared to SBI reagent, as
assessed by NTA size distribution, increased RNA concentration,
and lower small RNA Ct values. Similarly, the NB Urine Exosome
RNA Isolation Kit gave improved results for urine EV isolation
compared to ultracentrifugation, when determined by the same
parameters. For serum EV RNA isolation, the Qiagen miRNeasyTM RNA
Isolation Kit gave suitable EV RNA concentrations compared to
other kits, as assessed by Bioanalyzer and small RNA qRT-PCR.
Small RNAs HY3 (SD1.77, CoV6.2%) and U6 (SD2.14,
CoV8.6%) were selected as optimal ECs for serum EV miRNA
expression analysis, while HY3 (SD1.67, CoV6.5%) and RNU48
(SD1.85, CoV5.3%) were identified as suitable for urine studies.
Conclusions: This study identifies optimal methods for isolation of
serum and urine EV RNA, and suitable ECs for normalization of
qRT-PCR studies. Such reports should aid in the standardization
of EV microRNA data, particularly for biomarker studies.
Poster 4
Circulating microRNAs as biomarkers for acute
graft versus host disease
Rachel E. Crossland1, Jean Norden1, Kile Green1,
Mateja Kralj Juric2, Hildegard T. Greinix2 and
Anne M. Dickinson1
1Haematological Sciences, Institute of Cellular Medicine, Newcastle
University, Newcastle upon Tyne, UK; 2Department of Internal Medicine,
Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
Background: Graft versus host disease (GvHD) is a major cause of
morbidity and mortality in haematopoietic stem cell transplantation
(HSCT) and despite recent advances, the incidence remains high
(2050%). Acute GvHD (aGvHD) can double the cost of a transplant
and severe disease is associated with 4060% mortality. A novel,
non-invasive diagnostic test that predicts for the aGvHD incidence
and severity would enable more timely prophylactic therapy,
reducing morbidity and health care costs. Recently, microRNAs have
been demonstrated as informative biomarkers in bodily fluids,
where they are protected from degradation by extracellular vesicle
(EV) encapsulation or protein binding. In this study we profiled
patient serum (n12) for microRNA (n800) expression at aGvHD
diagnosis, using nCounter technology. Potential diagnostic micro-
RNAs were assessed for their prognostic potential prior to GvH
onset, and the small extracellular vesicle (EV) fraction investigated.
Materials and methods: A total of 12 serum samples were selected
from patients undergoing allo-HSCT (2014). Total RNA was isolated
from 1 ml serum (Norgen Biotek Total RNA kit) and assessed using
the Bioanalyzer (RNA Pico Kit). RNA was profiled using the nCounter
Human v3 miRNA Expression Assay Kit (NanoString Technologies).
Individual microRNAs were evaluated in independent diagnostic
(n32) and prognostic (n34, n47) cohorts by TaqMan qRT-
PCR. Small EVs were isolated using Total Exosome Isolation Reagent
(Invitrogen) and total RNA isolated with the Total RNA kit (Norgen
Biotek). Results: Sixty-one microRNAs were differentially expressed
between aGvHD vs. noaGvHD patients by nCounter profiling (34/27
up/down-regulated in GvHD, pB0.05). Down-regulated microRNAs
associated with GvHD/immunity (miR-146a, miR-30b & miR-374)
were assessed by qRT-PCR in an independent cohort of diagnostic
aGvHD serums, collected from a separate Institution (n32).
MiR-146a (p0.005), miR-30b (p0.004) & miR-374 (pB0.001)
were significantly down-regulated in aGvHD at onset vs. no-GvHD,
confirming their diagnostic potential. MiR-146a was assessed in
patient serum samples taken prior to aGvHD onset (Day 14, n34).
Expression was significantly up-regulated in aGvHD vs. no-GvHD
(p0.02), significantly associated with disease grade (p0.01) and
validated in an independent cohort (n47, p0.05). Assessing
D14 EVs, miR-146a was down-regulated in aGvHD vs. no-GvHD
in a pilot (n15, p0.06) and validation (n47, p0.02) cohort.
Work is ongoing to assess additional microRNAs of the nCounter
signature. Conclusions: Results demonstrate the capacity for circulat-
ing microRNAs to act as diagnostic and prognostic biomarkers
for aGvHD. Differential expression between whole serum and the EV
compartment prior to aGvHD onset suggests a role for EV microRNAs
in the biology of aGvHD, which warrants further investigation.
Poster 5
Differences in circulating extracellular vesicles between
healthy volunteers and patients with established erectile
dysfunction  do endothelial microvesicles play an
ambivalent role?
Justyna Karolina Witczak1, Nicholas Burnley-Hall1, Fairoz Abdul1,
Vitaliy Androshchuk1, Nicholas Ossei-Gerning2, Richard Anderson2,
Aled Rees1and Philip James3
1Department of Endocrinology and Diabetes, Institute of Experimental and
Molecular Medicine, School of medicine, Cardiff University, Cardiff, UK;
2Cardiovascular Biology and Medicine, University | Hospital of Wales, Cardiff,
UK; 3Metabolic Health, Cardiff Metropolitan University, Cardiff, UK
Background: Plasma extracellular vesicles (EVs) may serve as biomar-
kers of cardiovascular disease (CVD). Erectile dysfunction (ED) and
CVD share common pathophysiological mechanisms of which
endothelial dysfunction is an early marker. Patients with ED may thus
represent a risk group for CVD. We hypothesized that EVs might be
elevated in patients with ED and/or display altered surface character-
istics indicative of a heightened vascular risk. The aim of this project
was to compare plasma EVs concentration and cellular origin in
patients with ED9CVD with healthy volunteers (HV). Methods: Blood
samples were obtained from patients with established ED (n20,
CVD n14, no CVD n 6) and healthy volunteers (n21). EVs were
isolated by ultracentrifugation as per local protocol. EVs size and
concentration were determined by nanoparticle tracking analysis
(Nanosight LM10); Time Resolved Fluorescence (TRF)-based ELISA was
used to establish cellular origin using the following markers: CD41
platelets, CD11b leukocytes, CD235a erythrocytes, CD144 endothelial
cells, CD9 exosomal marker. Results: There were no significant
differences in EVs concentration between ED patients and healthy
volunteers. However, analysis of cellular origin revealed significantly
higher CD41 TRF signals in patients with ED vs. HV (12,0909754.7 vs.
8,2109941.7, pB0.005) and significantly lower CD144 TRF signals
(1,1859203.5 vs. 5,51191,072, pB0.001). There were no statistically
significant differences in CD11b, CD235a and CD9 TRF signals
(10122.794,042 vs 10737.8912,459, pns, 2218.991643.6 vs.
3834.993899.3, p0.096, 26,773910,121 vs. 22,460912,274, pns
respectively). In a sub-analysis of ED() CVD() compared to
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ED()CVD() samples, no further differences in EVs cellular origin
were observed. Conclusions: A higher proportion of platelet-derived
EVs in patients with ED is in keeping with ED as a disease state sharing
a common vascular origin with CVD. The role of endothelium-derived
EVs has recently been questioned. Traditionally, they were believed to be
a marker of endothelial damage but recent data suggest their role in
vascular homeostasis is much more complex and in fact, they might
support endothelial regeneration and counteract coagulation.
Poster 6
Vascular smooth muscle cell exosomes thrombogenic activity is
regulated by prothrombin recycling
Alexander N. Kapustin1, Leon J. Schurgers2, Michael Schoppet3,
Paul Harrison4 and Catherine M. Shanahan1
1BHF Centre of Research Excellence, King’s College London, London, UK;
2Cardiovascular Research Institute CARIM, University of Maastricht, Maastricht,
the Netherlands; 3Department of Internal Medicine and Cardiology, Phillips
University, Enid, UK; 4School of Immunity and Infection, University of
Birmingham, Birmingham, USA
Background: Rupture of the fibrous cap in atherosclerotic lesions is
associated with thrombus formation initiated by phosphatidylserine
(PS)-enriched microparticles thought to originate from apoptotic cells.
We recently showed that loss of contractile phenotype by vascular
smooth muscle cells (VSMC) induces exosomes secretion and here we
tested VSMC exosomes thrombogenicity. Methods: VSMCs exosomes
and apoptotic bodies (AB) were isolated by differential ultracentrifu-
gation. To study uptake human PT was labelled with Alexa488 and
incubated with VSMCs. Thrombin generation was measured by
fluorescence spectroscopy (Fluoroskan Ascent FL, Thermo Electron
Corporation). Results: We found that VSMC exosomes but not
apoptotic bodies were enriched with tissue factor (TF) and able to
bind prothrombin (PT) and stimulate thrombin generation via the
prethrombin-2 pathway in a fashion similar to activated platelets.
Notably, PT was rapidly taken up by VSMCs in a calcium-dependent
manner and loaded into exosomes along with the potent thrombin
inhibitor, protease nexin-1 (PN-1). Prothrombin loaded into VSMC
exosomes was resistant to activation by factor Xa and decreased
exosome thrombogenic activity most likely by occupation of available
PS sites. Conclusions: Taken together this data indicates that VSMC
exosomes are novel potent activators of the extrinsic coagulation
pathway in the vasculature acting via a platelet-like mechanism.
Exosome coagulation activity is negatively regulated by a feed-back
loop involving PT internalization and recycling via the exosome
pathway, which acts to block further PT activation thereby preventing
overwhelming vascular thrombogenesis.
Poster 7
Osteocyte-derived microvesicles modulate adipocyte and osteoclast
differentiation: a role for microvesicles in cellcell communication
in bone?
Nicole E. E. Scully1,2*, Georgios Kremastiotis1,3*, Rob D. Young4,
Michael Stone5 and Bronwen A. J. Evans1,2
1Institute of Molecular and Experimental Medicine, School of Medicine,
Cardiff University, Cardiff, UK; 2Arthritis Research UK Biomechanics and
Bioengineering Centre, Cardiff University, Cardiff, UK; 3Faculty of Pharmacy,
National and Kapodistrian University of Athens, Athens, Greece; 4School of
Optometry and Vision Sciences, Cardiff University, Cardiff, UK; 5Bone Research
Unit, University Hospital Llandough, Penarth, UK.
*Joint first authors.
Background: Osteocytes in vivo are derived from osteoblasts and are
embedded in the mineralized matrix of bone. They contribute to the
regulation of bone turnover by signalling to other cell types, but
these pathways are not fully understood. It is possible that some of
these pathways involve extracellular microvesicles (MVs), although
there is very little published literature on the production and
function of MVs by bone cells. This study investigated the effects
of conditioned medium (CM) and MVs derived from osteocytes on
(a) adipocyte, (b) osteoblast and (c) osteoclast differentiation in
vitro. Methods: Mouse IDG-SW3 CM collected during osteoblast to
osteocyte differentiation (341 days) in monolayer CM was stored at
808C or ultracentrifuged (100,000 rpm, 48C, 2 h) to pellet MVs. MVs
were characterized by (a) TEM, (b) nanoparticle tracking analysis
(NTA) or (c) assessment of total protein concentration. For adipogen-
esis, 7F2 cells were cultured in a-MEM, 10% FCS, 50 mM indometha-
cin, 50 mg/ml ascorbate-2-phosphate and 107 M dexamethasone
for 36 days and stained with Oil Red O. For mineralization the same
cells were maintained in a-MEM, 10% FCS, 50 mg/ml ascorbate-2-
phosphate and 10 mM b-glycerophosphate for 12 days and stained
with Alizarin Red. For osteoclastogenesis, RAW cells were cultured in
a-MEM, 10% FCS and were primed with RANKL (2 ng/ml) for 3 days,
prior to treatment for 3 days and TRAP staining. Treatments in each
differentiation assay were either CM (1060%), MV-depleted CM
following ultracentrifugation, or MVs (20150 mg). Results: IDG-SW3
osteocytes secrete particles that resemble MVs as shown by TEM.
The particle concentration in CM collected during osteocyte
differentiation (1341 days) was 1.48e08  3.8e08/ml, with a
mean size of 194.29 nm. The protein concentration in MV prepara-
tions ranged from 250 to 400 mg/150 ml. Adipogenesis was increased
(pB0.05) by CM (day 730) and by MVs (20 or 40 mg) from day 14
(pB0.05, 40 mg) or day 17 (pB0.05, 20 mg) onwards. However,
adipogenesis was reduced (pB0.01) by MV-depleted CM for days
721. Mineralization was not modulated by CM or MV-depleted CM
collected on days 27 and 30. Following RANKL priming, MVs (100
150 mg) increased (pB0.01) osteoclastogenesis, whereas MV-
depleted CM did not have any effect. Conclusion: Osteocytes secrete
large numbers of protein-containing MVs. Both CM and MV
preparations stimulated adipogenesis, but MV-depleted CM had a
reduced effect when compared to non-depleted medium, indicating
a role for these MVs in adipogenesis. The results also indicate that
MVs have a potential role in osteoclastogenesis. This work supports
the hypothesis that osteocyte-derived MVs play a role in osteocyte
communication with other cell types.
Poster 8
Excluded on request of the authors
Poster 9
Excluded on request of the authors
Poster 10
Investigation of exosome miRNA content, stoichiometry and
functionality in a human neural stem cell line
Lara Stevanato, Lavaniya Thanabalasundaram, Nickolai Vysokov
and John Sinden
ReNeuron, Surrey Research Park, Guildford, UK
Background: Exosomes (30100 mm) are small membrane vesicles
secreted by a variety of cell types and have only recently emerged
as a new avenue for cell-to-cell communication. They are natural
shuttles of RNA and protein cargo, making them attractive as potential
therapeutic delivery vehicles. MicroRNAs (miRNA) are short non-
coding RNAs and regulate biological processes. Here we characterized
the miRNA contents of exosomes derived from human neural stem
cells (hNSCs). Our studied hNSC is a clonal conditionally immortalized
cell line suitable for banking according to quality controlled good
manufacturing practice (GMP). HNSCs have shown multipotent
capacity to ameliorate neurological vasculature deficits and blood
flow in the cerebral ischaemia and in the limb ischaemia rodent model,
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respectively, and have been approved for stroke disabilities and
critical limb ischaemia clinical trials. Methods: Identification and
characterization of ultracentrifuged hNSC exosomes were performed
using nanoparticle tracking analysis, qNano and western blot.
Next generation sequencing (NGS) was utilized to assess exosomal
miRNA content and compare it to cellular content. Real-time PCR was
adopted to investigate stoichiometry. Validation of miRNA function-
ality was performed using a miRNA/mRNA 3’ untranslated target
region (3’UTR) dual luciferase system. Results: By using NGS we
identified the presence of a variety of miRNAs. Many of these miRNAs
were enriched in exosomes indicating that cells specifically sort them
for extracellular release. Although exosomes have been proven to
contain miRNAs, the quantification in terms of copy number of a
specific miRNA type per exosome is unclear. In here we quantified the
copy number of an exosomal up-shuttled miRNA subtype (hsa-miR-
1246) and calculated its stoichiometry per exosome. Furthermore, we
developed an in vitro system to empirically investigate its functionality
and confirmed that the exosome preparation could transfer functional
moiety of miRNA in recipient cells. Conclusions: NGS analysis allowed
the identification of a unique set of hNSC-derived exosomal miRNAs.
Stoichiometry and biological functional analysis of one of the most
abundant identified miRNA, hsa-miR-1246, was measured to support
therapeutic potential of exosomal miRNA delivery.
Poster 11
Mining the sorting machinery of exosomal miRNAs in neural
stem/precursor cells
Nunzio Iraci, Tommaso Leonardi, Anton J. Enright and Stefano Pluchino
EMBL-EBI, University of Cambridge, Cambridge, UK
Background: Neural stem/precursor cell (NPC) transplantation pro-
tects the central nervous system from inflammatory damage via cell-
to-cell communication mechanisms. Recent works suggest that the
exosome-mediated transfer of molecules such as miRNAs might
play an important role in mediating the protective effect of NPCs.
Here we aim to identify the machinery that sorts miRNAs to
exosomes in murine NPCs. Our hypothesis is that such a mechanism
might work: (a) at the transcriptional level, with transcription factors
(TFs) driving specifically the transcription of exosomal miRNAs; or (b)
at the post-transcriptional level, with carrier proteins that recognize
specific miRNAs, bind to them and export them to exosomes.
Methods: We used RNA-Seq to identify miRNAs significantly more
abundant in exosomes than parental cells. To address whether
specific TFs drive the transcription of secreted miRNAs, we first
identified their putative promoters and then we tested if any TF
binding site is enriched in these regions. In parallel, we used a variety
of motif enrichment tools available in R/Bioconductor (Cosmo,
BCRANK, motifRG) to find short motifs enriched in secreted miRNAs.
Results: We found that no specific TF binding site is enriched in the
promoters of secreted miRNAs. However, we identified 2 short motifs
over-represented in exosomal miRNAs, one of which matches the
binding sequence of hnrnpa2b1, which previous works have shown
to be involved in miRNA secretion. Using western blot we found
that hnrnpa2b1 is present within NPC-derived exosomes, suggesting
that even in our cellular context this RNA binding protein may be
involved in miRNA secretion. Conclusion: The exosomal miRNAs do
not seem to be regulated by specific TFs. At the moment we are
validating the role of the 2 motifs in relation to the candidate carrier
hnrnpa2b1 for miRNA secretion in NPCs. Altogether, this work will help
to shed light on the molecular mechanism behind miRNA trafficking
and on its implication on the therapeutic effect of transplanted NPCs.
Poster 12
miR-134 in extracellular vesicles reduces TNBC aggression and
increases drug sensitivity
Michelle C. Lowry1, Keith O’Brien1, Claire Corcoran1, Vanesa G. Martinez1,
Melissa Daly1, Sweta Rani1, William M. Gallagher2, Marek W. Radomski1,
Roderick A. F. MacLeod3 and Lorraine O’Driscoll1
1School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical
Sciences Institute, Trinity College, Dublin, Ireland; 2Cancer Biology and
Therapeutics Laboratory, Conway Institute, UCD School of Biomolecular and
Biomedical Science, Dublin, Ireland; 3Leibniz Institute DSMZ, German
Collection of Human and Animal Cell Cultures, Braunschweig, Germany
Background: Exosomes (EVs) have relevance in cell-to-cell commu-
nication carrying pro-tumorigenic factors that participate in onco-
genesis and drug resistance and are proposed to have potential as
self-delivery systems. Advancing on our studies of EVs in triple-
negative breast cancer (TNBC), here we comprehensively analysed
isogenic cell line variants and their EV populations, as well as breast
tumour and normal tissues. The aim of this project was to profile the
miRNA contents of both TNBC-derived EVs and cells to identify
miRNAs which may have therapeutic potential in TNBC and to exploit
these EVs as therapeutic miRNA delivery vesicles to reduce TNBC
aggression and increase TNBC drug sensitivity. Methods: Assessing
miRNA content in TNBC isogenic cell line variants Hs578T and
Hs578Ts(i)8 using low density arrays representing 384 miRNAs. Using
GEO2R, assessing miR-134 levels in breast tumour vs. normal breast
tissue using 2 publically available tumour datasets, GSE26659 and
GSE40525. Investigating transcriptional silencing at chromosome
14q32.2 using qRT-PCR for the neighbouring MEG3/DLK1 loci.
Investigating the effects of directly over-expressing miR-134 in TNBC
cell lines to assess TNBC aggression (proliferation) and cisplatin drug
sensitivity (Annexin/PI assay). Investigating the ability of EVs to
transport miRNAs of choice to secondary cells, to determine cell
aggression (migration and invasion assays) and sensitivity to anti-
cancer drugs. Results: miRNAs profiling showed EV miRNA content
to be highly representative of their cells of origin. miRNAs most
substantially down-regulated in aggressive cells and their EVs
originated from 14q32. Using 2publically-available tumour datasets,
GSE26659 and GSE40525 analysis of miR-134, the most substantially
down-regulated miRNA, supported its clinical relevance in breast
tumours compared to matched normal breast tissue. Functional
studies indicated that miR-134 controls STAT5B which, in turn,
controls Hsp90. miR-134 delivered by direct transfection into
Hs578Ts(i)8 cells (in which it was greatly down-regulated) reduced
STAT5B, Hsp90, and Bcl-2 levels, reduced cellular proliferation, and
enhanced cisplatin-induced apoptosis. Delivery via miR-134-enriched
EVs also reduced STAT5B and Hsp90, reduced cellular migration
and invasion, and enhanced sensitivity to anti-Hsp90 drugs.
Conclusion: While the differing effects achieved by transfection or
EV delivery are likely to be, at least partly, due to specific amounts of
miR-134 delivered by these routes, these EV-based studies identified
miRNA-134 as a potential biomarker and therapeutic for breast
cancer.
Conflict of interest and funding
Irish Cancer Society’s support of Breast-Predict [CCRC13GAL]; Marie
Keating Foundation; HRB of Ireland [HRA_POR/2013/342]; HEA PRTLI
Cycle 5 funding of TBSI; and EU H2020 funding of the Cooperation in
Science and Technology ME-HAD [BM1202].
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Extracellular vesicle signalling in the oral cancer microenvironment
Mark Ofield, Daniel Lambert and Stuart Hunt
Unit of Oral and Maxillofacial Pathology, The School of Clinical Dentistry,
University of Sheffield, Sheffield, UK
Background: Oral cancer mortality rates have increased by 10%
in the last decade. Efforts to reverse this are hampered by a
limited understanding of the underlying molecular complexity of the
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disease. Recently, interest has grown in the contribution of
extracellular vesicles (EVs) to cancer pathogenesis. EVs are produced
by most cell types, but are produced in much higher quantities by
cancer cells. Since the discovery of mRNA and miRNA in EVs they
have been considered as an extracellular signalling system capable
of exerting effects on local or distant cells. Developing tumours exist
as a complex milieu comprising multiple cell types each capable of
producing a range of different EVs with pleiotropic functions. The
aim of this work is to explore the role of EVs and in particular their
RNA cargo, in oral cancer progression. Methods: EVs were extracted
from the culture media of oral cancer cell lines using ultracentrifu-
gation or size exclusion chromatography and then characterized
using a combination of transmission electron microscopy, tuneable
resistive pulse sensing and western blotting. EVs were labelled with
fluorescent markers and transferred to cells of a different line to
examine the ability of EVs to transfer RNA. Results: We have
successfully isolated EVs from a panel of cell lines representative
of the stages of oral cancer development and confirmed their
presence by western blot and transmission electron microscopy
showing them to be between 50 and 200 nm and bearing common
markers including CD63. Using fluorescent dyes, the horizontal
transfer of RNA between oral cancer cells and normal stromal cells
has been visualized. Conclusion: Using a combination of techniques
the existence of an EV transfer network in the oral cancer
microenvironment has been revealed. Future work will identify the
RNA and protein cargo of the isolated EVs in order to reveal the roles
they play in oral cancer progression.
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Background: Exosomes (50100 nm) are secreted by many cell types
and are formed within intraluminal vesicles of multivesicular bodies
(MVBs), which are released upon plasma membrane fusion. Exo-
somes appear to contribute to the cross-talk between cancer and
stromal cells generating a tumour-supporting stromal phenotype.
Our group demonstrated that prostate cancer cell (Du145)-derived
exosomes triggers myofibroblastic differentiation, resembling stro-
mal cells isolated from cancerous prostate tissue. These cells
supported angiogenesis in vitro and accelerated tumour growth in
vivo. However, the molecular factors controlling exosome secretion
are poorly understood. The most well-characterized factor-Rab27a
modulates exosome secretion in prostate cancer cells, and its
knockdown attenuates cancer to stroma communication blocking
myofibroblast differentiation. Here, we examined the roles of some
other putative exosome-regulating factors (CD9, Rab5a, Rab11b,
Rab35, VAMP7 and VPS25) for their roles in exosome biogenesis/
secretion and their importance in stromal activating capacity.
Methods: The role of these 6 genes in exosome biogenesis/secretion
was investigated using a short hairpin RNA (shRNA) lentiviral-based
silencing approach in Du145 cells. Nanosight tracking analysis (NTA)
and ELISAs were performed to examine exosome secretion levels in
all Du145 knockdowns (Du145KDs). Cell viability and their functional
capacity to drive fibroblast differentiation were studied in 2D cell
models. To assess the functional impact of Rab27a silencing, a 3D-
heterotypic cell spheroid model was established by mixing Du145
cells with primary stromal fibroblasts in cell-repellent surface plates.
Tumour invasiveness was assessed by monitoring outgrowth from
established spheroids cultured on matrigel-coated plates. Results: We
show successful target knockdown at both the mRNA and protein
level. Knockdown of the VPS25 gene led to some reduced cell
viability, but morphologically all Du145KDs look normal. Interest-
ingly, some of the Du145KDs (Rab35 and VPS25) appear to reduce
exosome secretion levels as determined via NTA and ELISAs.
Conditioned media from all Du145KDs cells appear to be deficient
in factors driving fibroblast differentiation. In a 3D co-culture model,
fibroblasts and exosome-competent tumour cells were required for
robust tumour invasion into a matrix. Conclusion: We demonstrate
that stromal cells are required for the invasive properties of tumours.
However, this effect requires exosome secretion by cancer cells.
Future work will investigate each target for its relevance in this
model, and establish the importance of exosome secretion in
stromally driven disease progression.
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Background: Association of macromolecular therapeutics to vectors
that increase cell uptake and protect from extracellular and
intracellular degradation is a vital step in the creation of more
efficient drug delivery systems for intracellular targets. Exosomes are
natural, extracellularly expelled components of the endocytic system
that are often loaded with materials such as nucleotides, peptides
and proteins. These are the very entities that show promise as
biopharmaceuticals. The fact that exosomes interact with and deliver
macromolecules such as miRNA to cells to mediate a physiological
effect suggests that they have potential as drug delivery vectors.
However, the mechanisms by which exosome-cell interaction, route
of cell entry and possible escape from the endolysosomal system
occur, are unknown. The aim of our work is to characterize the cell
uptake mechanism of exosomes in order to provide a greater
understanding of how they may be able to deliver macromolecular
cargo into the cytosol to mediate therapeutic effects. Methods:
Prostate-derived exosomes were purified (1) and then conjugated to
a fluorescent label to allow cell uptake analysis via live cell imaging
confocal microscopy. To access the extent of involvement of
different endocytic pathways, siRNA transfection targeting specific
endocytic proteins and pharmacological inhibitors of endocytosis
were utilized. Uptake was analysed in HeLa cells due to the fact that
their endocytic profile has been extensively studied in the laboratory
(2). Results and discussion: Exosomes were effectively internalized
into HeLa cells and located in highly motile punctate structures
scattered around the cytoplasm. Depletion of key endocytic proteins
via siRNA indicated that proteins implicated in macropinocytosis
(a growth factor-activated, actin-dependent form of constitutive
fluid-phase endocytosis) may be involved in the uptake of
these structures. Furthermore, the use of pharmacological inhibitors
previously used to study macropinocytosis (EIPA, Rottlerin, IPA-3)
also suggests the involvement of this pathway. These studies
also extended to analysis of dextran, the fluid-phase endocytic
probe that is also utilized to measure macropinocytosis. Currently it
is difficult to distinguish fluid-phase uptake from constitutive and
stimulated macropinocytosis. Complete characterization of the ways
that exosomes gain intracellular access will help to unlock their
potential for drug delivery, allowing their exploitation for therapeutic
use. Ultimately, this work aids an overall aim to improve the in vitro
characterization and in vivo delivery of macromolecular therapeutics
across biological barriers.
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Background: There is an ever-increasing interest in biofluid exosomes
as a biomarker source; however, a major challenge for proteomics
is isolating sufficient high purity exosomes for analysis. When
using mass spectrometry (MS) removal of abundant non-exosomal
protein is imperative. The aims were to: develop biofluid exosome
isolation methods, assess sample purity, and to test the workflow
using prostate cancer (PCa) patient-derived material. Methods:
Healthy donor plasma and urine was used as an exosome source
to test isolation methods including: ultracentrifugation (UC), filtra-
tion, gradient UC, and size exclusion chromatography (SEC). Purity
was tested using: ELISA-like assays, cryo-electron microscopy,
western- blot and nanoparticle tracking. We used a novel aptamer-
based protein array (SOMAscanTM) for proteomics analysis. Results:
Isolating exosomes from plasma using UC and gradient UC
insufficiently removed plasma proteins and gave inadequate purity,
measured by particle/protein (P/P) ratio. The use of SEC, however,
removed 95% of contaminating protein and effectively separated
EV-associated tetraspanins from serum albumin. Unfortunately,
even with an increase in sample purity this was still insufficient to
generate high quality datasets by LC/MALDI MS analysis (21 iden-
tifications, mostly plasma proteins). However, with the SOMAscanTM
platform we were able to identify hundreds of proteins that
were identified from urine- and plasma-exosome samples. Some
abundant non-vesicular proteins were still identified, particularly in
plasma, but this did not impede the identification of many vesicle-
associated proteins. Subsequently we applied this workflow to
paired urine and plasma samples from newly diagnosed metastatic
PCa with patients with progressive disease. We discovered that over
60 ml of urine was required in order to obtain the minimum amount
of protein required for the proteomic analysis, but 1.5 ml plasma was
sufficient. Based on this small pilot dataset (plasma n11; urine
n5) we used cluster analysis to examine the closest groups of
patients, identifying numerous proteins that may be of interest in
progressive PCa. These included immunological proteins, kinases
and HSP cognate proteins. Discussion: The workflow developed
shows the removal of 95% of contaminating protein and the en-
richment of exosomes. Upon analysis of the samples by SOMAscanTM
array it is possible to identify hundreds of proteins that discriminate
plasma from urinary vesicles, and also a set of proteins of potential
association with progressive PCa. This study has demonstrates the
practical utility of SEC exosome isolation coupled with the SOMAscanTM
assay for proteomics analysis of biofluid exosomes in clinical settings.
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Background: Much of the research into biomarkers for prostate cancer
has focused specifically on cancer cells. The tumour microenvironment
is, however, very complex and we may be overlooking other potential
sources of disease biomarkers. During disease the stromal tissue,
surrounding glandular structures of the prostate, becomes aberrantly
altered leading to the formation of a reactive stroma. This is often
regarded as a rate limiting step in disease, and is typically associated
with treatment-resistant disease and poor patient outcome. Such cells,
present within the tumour microenvironment, secrete exosomes
(nanometre-sized vesicles) that are detectable within the patient’s
circulatory system. Stroma-derived exosomes may therefore provide
an attractive source of novel biomarkers, capable of distinguishing
slow growing tumours from aggressive disease. The aim of the current
study was to compare exosome-derived mRNA from normal, or
tumour-associated, stromal cells in order to identify possible future
biomarkers for aggressive prostate cancer. Methods: Patient-matched
normal and tumour-associated stromal cells were cultured from
needle biopsies of radical prostatectomy specimens, taken from
disease-free or cancerous regions respectively. Exosomes were
isolated by serial filtration and ultracentrifugation, prior to determin-
ing exosome size and concentration by nanoparticle tracking analysis
(NanoSight; Malvern Instrument Ltd). Following phenol-based extrac-
tion, exosomal mRNA was analysed by quantitative RT-PCR using the
RT2 PCR profiler array (Qiagen). Finally, mRNA expression of potential
biomarkers was assessed in serum-derived exosomes, isolated by
size exclusion chromatography (Exo-spinTM; Cell Guidance Systems).
Results: Tumour-associated stromal cells secrete twice as much
exosome-associated mRNA compared to matched normal stromal
cells. Interestingly, our data also suggests a selective enrichment of
mRNA targets within exosomes compared to the cell of origin. From
the 84 genes tested, we identified more than 30 (e.g. Gremlin-1,
TGFbeta1, STAT1, HGF & VEGF) that were elevated in tumour stroma
exosomes compared to exosomes from the normal stroma. We have
demonstrated successful isolation of serum-derived exosomes, from
which we can detect several mRNA targets. Conclusion: This study not
only highlights the potential of using exosome-derived mRNA targets
as potential markers of aggressive prostate cancer, but specifically
mRNA targets present within stromal cell-derived exosomes. Future
work shall continue to validate key mRNA targets, identified within the
current study, and explore whether such biomarkers could distinguish
indolent from aggressive forms of disease.
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Background: The stromal tissue surrounding carcinomas is radically
altered and consists of cells with a myofibroblasts-like phenotype.
The presence of such cells is often regarded as a rate limiting step in
prostate cancer, and is associated with both treatment-resistant
disease and poor patient outcome. Whilst mounting evidence points
to a role of transforming growth factor beta (TGFb), the exact
mechanism regulating the onset of this disease-associated stromal
phenotype remains unclear. We have previously demonstrated
that exosomes can deliver TGFb and induce stromal cell differentia-
tion to a disease-like phenotype. Furthermore, we have implicated
heparan sulphate chains, present on the exosome surface, in the
delivery of functional TGFb. Here we characterize the expression
of heparan sulphate proteoglycans (HSPGs) present on prostate
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cancer exosomes and explore the relationship between HSPGs and
exosome-induced stromal cell differentiation. Methods: Prostate
cancer exosomes, isolated by flotation within 30% sucrose/D2O,
were characterized by immune-fluorescent analysis, nanoparticle track-
ing and western blot. A lentiviral-based shRNA approach was used to
selectively knockdown HSPGs in prostate cancer (Du145) cells. Patient-
matched normal or tumour-associated stromal cells were obtained from
prostatectomy specimens. Myofibroblast differentiation was determined
by the onset of a-smooth muscle actin (aSMA), and angiogenic function
was assessed by co-culture with endothelial cells (HUVECs). Results:
Exosomes from different prostate cancer cell lines express variable levels
of TGFb and we demonstrate a strong positive correlation between
levels of TGFb and HSPGs present on the exosome surface. TGFb-high
exosomes express syndecan 3, syndecan 4, glypican 1, glypican 6 and
betaglycan. We have generated prostate cancer cell lines that secrete
exosomes lacking specific HSPGs. These HSPG-deficient exosomes
show a reduced ability to drive stromal cell differentiation. Conclusion:
Exosomal, not soluble, delivery of TGFb is essential for generating a
disease-like stroma. This exosome function is dependent on heparan
sulphate proteoglycans, such as betaglycan, present on the exosome
surface. Exosomal-HSPGs may therefore represent novel targets for
attenuating tumour growth.
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Background: There is considerable interest in the use of exosomes as a
potential source of biomarkers in a variety of diseases, including
prostate cancer. The application of exosomes for this purpose is,
however, hindered by the difficulty of detecting cancer-derived
exosomes from other vesicles present within biofluids. In addition,
the presence of highly abundant soluble proteins can interfere
with downstream analysis of isolated exosomes, and even lead
to erroneous data. We have previously demonstrated the use of
Sepharose-based size exclusion chromatography columns as a means
of isolating exosomes from plasma. Furthermore, we have identified a
role of heparan sulphate proteoglycans (HSPGs), present on the
surface of prostate cancer exosomes, in facilitating tumour growth in
vivo. Here we demonstrate both the successful isolation of exosomes
from serum and development of an assay capable of detecting HSPGs
present on exosomes isolated from serum. Methods: Cell-free (donor)
serum was spiked with cell culture-derived prostate cancer exosomes.
Exosome isolation, from serum, was achieved using a Sepharose-
based size exclusion chromatography column (Cell Guidance Sys-
tems). From each column we collected 30 fractions, each 500 ml, eluted
from the column using 1.8 mg/ml EDTA in PBS. The presence of both
exosome-associated and soluble proteins present within the fractions
was examined by immuno-fluorescent analysis of fractions. Exosome
concentration for each fraction was then determined by nanoparticle
tracking analysis (NanoSight; Malvern Instruments Ltd), and total
protein content of each fraction was measured by BCA assay (Pierce;
ThermoFisher Scientific). The ratio of particles: protein was then used
as a measure of exosome purity. Results: Positive detection of CD81
within distinct fractions confirmed the detection exosomes within
the spiked serum samples. The exosome containing fractions were
distinct from those containing human serum albumin (HAS), and the
particle: protein ratios were elevated in the exosome containing
fractions, suggesting successful separation of exosomes from the bulk
of the soluble proteins present within serum. Finally, we were able to
detect elevated levels of HSPGs, including syndecan 4 plus glypicans 1
and 6, within the exosome containing fractions. Conclusion: Column
chromatography-based approaches offer a relatively fast and simple
means of isolating exosomes from biological fluids. We have devel-
oped a method for the detection of HSPGs present on exosomes
isolated from serum. Future studies shall explore whether exosomal-
HSPGs can serve as markers capable of distinguishing patients with
prostate cancer.
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Background: Exosomes are a distinct population of extracellular
vesicles of endocytic origin which express a phenotype and protein
repertoire similar to the cell of origin. Tumour-derived exosomes
harbour the immunosuppressive characteristics of tumour cells,
such as inhibition of IL-2 production by T cells (1). However, there
is relatively little known about the effect of exosomes on antigen
presenting cells such as dendritic cells (DC), which was the subject of
this work. Methods and results: We studied the effect of exosomes,
isolated from prostate cancer cells (DU145 cell line), on DC function.
For this, we used DU145 cells where Rab27a had been knocked down
(DU145 Rab27aKD) or treated with an empty vector (DU145 Control).
Rab27a is a molecule responsible for the release of exosomes from
intracellular multivesicular endosomes. Knockdown of Rab27a dras-
tically attenuated the secretion of exosomes. Cross-presentation of
the tumour-associated antigen 5T4 from DU145 Rab27aKD cells
generated significantly stronger anti-5T4 T cell responses compared
to that from DU145 Control cells. These enhanced T cell responses
were reduced again when tumour-derived exosomes were added back
to the cross-presentation model incorporating DU145 Rab27aKD
cells. We have excluded the direct effect of exosomes on T cell
function in this model, so the results suggested that exosomes exert a
negative effect on antigen presenting cells. When the phenotype of
DC exposed to exosomes was studied, we found that a significant
proportion of DC expressed CD73, an ecto-5-nucleotidase respon-
sible for AMP to adenosine hydrolysis. DC and monocytes express
CD39 (ectonucleotidase responsible for ATP-to-AMP hydrolysis),
however CD73 expression on DC has not been demonstrated
previously. Coexpression of CD39 and CD73 makes exosome-treated
DC uniquely capable of catalysing pro-inflammatory ATP from the
tumour microenvironment and replacing it with immunosuppressive
adenosine. Functionally, exosome-treated DC produced significantly
less IL-12 upon stimulation in the presence of ATP than control
DC. This cytokine shift may have further consequences, such as
suboptimal T cell activation. Conclusion: Taken together, the results
reveal a hitherto unknown effect of tumour exosomes on DC,
representing a significant immunosuppressive influence on tumour
cellimmune cell cross-talk.
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Background: The interactions between chronic lymphocytic leukaemia
(CLL) cells and the microenvironment (primarily composed by
mesenchymal stromal cells  MSC) play an important role in
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promoting the increased survival of leukemic B cells. Extracellular
vesicles (EVs) produced by leukemic cells and the microenvironment
may be implicated in this cross-talk. EVs, including microparticles and
exosomes, are small plasma membrane fragments with sizes ranging
from 0.01 to 1 m, and contain products specific to the original cell, such
as microRNA, mRNA and proteins. Our objective is to assess the role of
EVs in the cross-talk between malignant cells and their microenviron-
ment. Methods: Ultracentrifugation at 150,000g during 1 h was
applied to isolate EVs from supernatant of MSC culture. Protein
concentration was measured by BCA kit and NanoDrop. Different
concentrations of EVs were added to CLL-B-cells to evaluate their
impact on cell survival. PKH67 labelling and qRT-PCR were performed
to prove the inclusion of EVs in CLL B-cells (n18). Results: We first
demonstrated that EVs from MSCs are able to enter in CLL B-cells. By
flow cytometry with PKH67-labelled EVs, we observed that 44.2, 93.8
and 100% of CLL B-cells had integrated fluorescent EVs after 1, 3 and 24
h respectively. Two highly expressed mRNA (collagen and fibronectin)
in MSC, also detected in MSC-derived EVs by qRT-PCR, and were
increased in CLL B-cells after 24 h of incubation with EVs confirming
EV-mediated mRNA transfer to target cells. Further analysis of
apoptosis in CLL cells was assessed by flow cytometry using an
Annexin/7AAD staining: addition of increasing concentrations of EVs
showed a protective effect on CLL B-cells from cell death (n21/
pB0.0001). We also studied the effect of EVs from MSC on
proliferation (CFSE labelling), migration (Boyden chamber) and
chemoresistance of CLL B-cells after 24 h of contact. Conclusion: We
demonstrated, using 2 methods, that MSC-derived EVs enter into CLL
B-cells. These vesicles protect CLL cells from spontaneous apoptosis
and affect proliferation, migration and chemoresistance capacities of
CLL B-cells. Further analyses will determine implication of EVs in
several cell functions. This study provides evidence of the critical role
played by EVs in the interactions between leukemic cells and their
microenvironment.
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Background: Despite their propensity to promote inflammation,
neutrophils are one of few cell types whose microvesicles can
promote tissue protection. Activated neutrophils release large
numbers of microparticles which promote the resolution of inflam-
mation by affecting the function and phenotype of other inflamma-
tory cells. Of these, tissue macrophages are central to the recovery of
homeostasis after an inflammatory insult, although the effect of
microvesicles on these cells is not fully understood, particularly in the
context of rheumatoid arthritis. Methods: Neutrophils were stimu-
lated for 20 min with 50 ng/ml TNF or diluted synovial fluid (vesicle-
depleted) from rheumatoid arthritis patients and their microvesicles
were enriched by differential centrifugation and enumerated using
an ImageStream MkII as previously described (1). Macrophages were
differentiated from human blood monocytes in the presence of M-
CSF and phenotyped using flow cytometry and cytokine bead array.
The C28/I2 chondrocyte 3D micromass culture system was used to
quantify changes in chondrocyte cartilage deposition in vitro. Results:
Neutrophil-derived microvesicles impaired the classical activation of
macrophages by LPS and IFN (dependent on phosphatidylserine
exposure) but did not seem to promote an alternative phenotype in
the time studied (despite a phosphatidylserine-independent induc-
tion of TGFb release from macrophages). Macrophages activated
with IL-4 or neutrophil microvesicles (generated with different RA
relevant stimuli) promoted proteoglycan deposition/retention by
chondrocytes, whereas untreated and inflammatory mediator-
activated macrophages reduced deposition/increased degradation.
The chondrogenic properties of macrophages treated with neutro-
phil microvesicles was diminished upon blockade of TGFb or
microvesicle-associated annexin A1, the latter of which induced
release of the former. Conclusions: Neutrophils release large numbers
of annexin A1 microvesicles upon activation with inflammatory
stimuli, which can resist the pro-inflammatory, classical activation of
macrophages. Microvesicle-associated annexin A1 induces TGFb
release from macrophages which induces proteoglycan deposition
in chondrocytes. We propose the endogenous presence and/or
pharmacological use of neutrophil microvesicles as an autologous
therapeutic may promote resolution and improve cartilage integrity
in rheumatoid arthritis.
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Background: Regulatory T cells (Tregs) are a subset of CD4 CD25
FoxP3 T cells that are vital in suppressing excessive immune
responses. Tregs can inhibit the function of cells such as dendritic
cells (DCs) or T-effector cells via various different mechanisms. One
recently discovered mechanism is through the release of immune
modulatory exosomes. Exosomes are nano-sized extracellular vesi-
cles of endocytic origin that carry cargo, such as protein and
microRNA (miRNA), the delivery of which to cells alters their
phenotype and function. Recently, Okoye et al. showed that Let-7d
was present in Treg exosomes and this was transferred into T-helper
1 cells which suppressed their proliferation and prevented systemic
disease. Tregs can downregulate the activation receptors of DCs and
reduce their cytokine production, thus suppressing an immune
response. Our hypothesis is that Treg exosomes suppress DC
functions by transferring bioactive materials such as inhibitory
miRNAs. Methods: Exosomes were isolated from culture supernatants
of TCR activated mouse CD4 CD25 FoxP3 and CD4 CD25
FoxP3- T cells using ExoQuick solution. Total RNA was extracted from
exosomes using SeraMir columns. A complete miRNA content
analysis was performed using QuantStudio 12K Flex Real-time PCR
system and OpenArray plates. Individual real-time PCR validation
assays were performed and normalized using RNU6. DCs were co-
cultured with or without Tregs or Treg-derived exosomes for 24 h
before DCs were FACS sorted or purified and total RNA extracted for
miRNA content analysis. Results: A complete miRNA screen was
performed on exosomes isolated from CD4 CD25 FoxP3 and
CD4 CD25 FoxP3- T cells. We identified several miRNAs,
including miR-142-3p and miR-150, as being expressed significantly
higher in exosomes isolated from Tregs compared to T cells. Given
that both miR-142-3p and miR-150 play important roles in DC
maturation and function such as phagocytosis and cytokine release,
we investigated whether acquisition of these miRNAs via Treg
exosomes facilitated modulation of DCs cytokine release. We
observed that DCs cultured in the presence of Tregs or Treg
exosomes expression levels of both miR-142-3p and miR-150 were
higher than DCs alone. This correlated with the reduced capacity of
DCs to produce IL-12 following TLR ligation compared to untreated
DCs. Conclusions: Our data confirms the presence of miRNAs in Treg
exosomes and suggests that intercellular transfer of Treg miRNAs via
exosomes may be a novel mechanism by which these cells regulate
DC activity. Further work is needed to understand the messenger
RNA targets of these miRNAs and the protein levels affected.
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T-regulatory-cell-derived exosomes suppress pathogenic T helper
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Background: Graft versus host disease (GvHD) remains a significant
cause of morbidity and mortality following haematopoietic stem cell
transplantation, therefore developing novel therapeutic strategies is
the target of significant research. Clinical trials using regulatory T
cells (Treg) have shown promising results for both prevention and
treatment of GvHD; however, their mechanisms of action remain to
be fully clarified. We have previously shown Treg are able to
modulate DC function and therefore reduce GvH reactions in vitro.
We hypothesized this modulation could be through the release of
extracellular vesicles (EVs) with immuno-modulatory properties,
providing the opportunity to develop a new form of Treg-mediated
treatment for GvHD. Methods: Treg were isolated from leukocyte
reduction system cones, due to the rarity of Treg cells in peripheral
blood, ex vivo expansion of Treg for 23 weeks was required. All
Treg were phenotypically and functionally characterized prior to use.
Before EV isolation, Treg were cultured in EV-depleted medium for
48 h. EVs were isolated by differential ultracentrifugation, collecting
both the 10,000 g and 100,000 g pellets. The EVs were then
characterized using flow cytometry, transmission electron micro-
scopy (TEM), BCA protein quantification and nanoparticle tracking
analysis. The functional properties of EVs were investigated by
treating monocyte-derived dendritic cells (moDC) with both the
10,000 g and 100,000 g pellets and assessing their phenotype,
antigen processing capacity and ability to stimulate T cells. Results:
EVs were successfully isolated from 50 to 200106 Treg following
anti-CD3/CD28 stimulation. Flow cytometry analysis showed enrich-
ment of CD63, CD9 and CD81 on both the 10,000 g and 100,000 g
pellets, with the highest levels on the 100,000 g pellet. TEM revealed
the presence of EV, with those from the 100,000 g pellet having the
typical cup-shaped morphology. Preliminary data has shown treat-
ment with both the 10,000 g and 100,000 g EV pellets, resulted in a
dose-dependent reduction in expression of co-stimulatory and
maturation markers on moDC. Expression of CD38, CD80, CD83,
CD86 and HLA-DR were all decreased following LPS maturation
when compared to untreated moDC. Additionally the EV-treated
moDC showed a reduction in antigen processing capacity, measured
by FITC-dextran uptake. Conclusions: Preliminary results suggest that
treatment of moDC with Treg-derived EVs alters their ability to
mature in response to the TLR-4 ligand LPS which is likely to result in
a reduction in their capacity to stimulate T cells. Further work is
required to investigate the impact of this on GvH reactions in vitro.
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Stability of extracellular vesicles during lyophilization  implications
for their pharmaceutical use
Gregor Fuhrmann and Molly M. Stevens
Department of Materials, Department of Bioengineering, Imperial College
London, London, UK
Background: Recently, extracellular vesicles (EVs) have attracted
substantial attention as promising drug carriers for various applica-
tions (1,2). They were shown to possess natural composition and
inherent stability under physiological conditions (3). When develop-
ing EVs as pharmaceutical delivery systems, lyophilization (freeze-
drying) plays an important role for their storage and transportation
but to date this has been poorly investigated. Here, we assessed the
fundamental and important implications of freeze-drying and
addition of different cryoprotectants on EV size and stability.
Methods: EVs were isolated from human mesenchymal stem cells
(average cell number 35 M) cultured in serum-free medium
(TheraPEAKTM medium, Lonza) for 48 h. Conditioned medium was
subjected to differential centrifugation (20 min at 300g and
4,200g, respectively) with a final spin-down of EVs at
120,000g at 48C for 2 h, and resuspended in PBS. Samples were
lyophilized or stored at 4 or 808C. EVs were lyophilized as is or
upon addition of polyethylene glycol (PEG, Mw 400) or mannitol
(both 0.520% w/v). For size determination, all samples were diluted
to 100 ml and analysed by nanoparticle tracking analysis and electron
microscopy upon negative stain with uranyl acetate. Results: Upon
lyophilization of EVs without any additives their average size was
192939 nm, compared to 184921 and 181922 nm during storage
at 4 and 808C, respectively. Electron microscopy analysis indicated
that freeze-drying did not significantly alter the size and morphology
of EVs. The normalized particle number did not significantly change
for direct lyophilization of EVs compared to storage at 4 or 808C
but variations between samples were observed. Addition of PEG
induced a significant increase in EVs’ average size and particle
distribution, indicating that the polymer may induce aggregation of
EVs during lyophilization. When freeze-drying with cryoprotecting
sugars such as mannitol, the EVs’ size distribution, and particle
number remained stable up to 4% (w/v) of sugar indicating that low
concentrations of mannitol offer suitable cryoprotection for EVs.
Conclusions: Our results indicate that EVs exhibit natural stability during
lyophilization, a characteristic further underlined by the addition of
cryoprotecting sugars. With this work we are establishing the important
basis for the successful use of EVs in a pharmaceutical setting.
References
1. Gregor Fuhrmann, Inge K. Herrmann, Molly M. Stevens. Cell-
derived vesicles for drug therapy and diagnostics: Opportunities and
challenges. NanoToday 10(3):397409.
2. Gregor Fuhrmann, Andrea Serio, Manuel Mazo, Rekha Nair, Molly M.
Stevens. Active loading into extracellular vesicles significantly improves
the cellular uptake and photodynamic effect of porphyrins. J Control
Release 2015 205;3544.
3. EL Andaloussi S, Ma¨ger I, Breakefield XO, Wood Mathew. Extra-
cellular vesicles: biology and emerging therapeutic opportunities.
Nat Rev Drug Discov. 2013 May;12(5):34757. doi: http://dx.doi.org/
10.1038/nrd3978
Poster 28
Potential alternatives to gold standard ultracentrifugation
for extracellular vesicle isolation
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Background: Exosomes/extracellular vesicles (EVs) are a class of
membrane-bound vesicles released from a number of cell types.
These nano-sized (30130 nm) structures may specifically package
certain nucleic acids and protein from their cell of origin and so
represent a potential novel source of circulating biomarkers. How-
ever, studies of these EVs are impeded by a lack of standardization in
methods of isolation and characterization. Here we compare
standard ultracentrifugation (UC) methods and commercially avail-
able kits to determine if a more high throughput method for EV
isolation exists and if it is comparable to the current gold standard in
terms of EV purity. Methods: EVs were isolated from 1 ml aliquots of
pooled serum specimens using 6 methods: filtration/UC, UC with
sucrose cushion, UC with Optiprep density gradient, size exclusion
chromatography (Izon Science), Total Exosome Isolation Reagent
(TEI) (Invitrogen) and ExoSpin (Cell guidance systems). EV isolates
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were characterized by transmission electron microscopy (TEM),
nanoparticle tracking analysis (NTA), immunoblot and protein
quantification assay. Results: TEM analysis confirmed the presence
of EVs of the expected size in all methods apart from the TEI and
ExoSpin methods which either had far too much material to
distinguish individual EVs or had EVs of a larger size respectively.
NTA also confirmed the presence of larger particle sizes in the TEI
and ExoSpin methods. Immunoblots show EV positive markers
TSG101 and CD63 or CD81 present in EVs isolated using all methods.
Four of the methods were negative for EV negative marker GRP94
(94 k Da); however, EV isolates from the TEI and ExoSpin methods
were negative for GRP94 at 94 kDa but were positive for a GRP94
subunit at 24 kDa. Protein quantification shows discernibly higher
amounts of protein in TEI and ExoSpin methods compared to other
methods. Conclusion: Here we examine the capabilities of commer-
cially available and ultracentrifugation-based EV isolation methods
using serum. Standard UC and UC with sucrose cushion out-
performed other methods on reproducibility and on purity of EVs.
As of yet there seems to be no advantage in alternative methods to
the gold standard method of ultracentrifugation.
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Purification of extracellular vesicles using in-house size exclusion
chromatography columns
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Background: The purification of extracellular vesicles can be challen-
ging. EVs isolated by ultracentrifugation have been shown to be
contaminated with protein aggregates and large protein complexes.
Similarly, density gradient ultracentrifugation preparations can
be contaminated with high-density lipoproteins. This can have a
confounding impact on downstream applications such as proteo-
mics analysis. We sought to develop in-house size exclusion
chromatography (SEC) columns capable of isolating EVs suitable
for proteomics and next generation sequencing analysis. Methods:
Components of conditioned medium from cancer cell lines were
separated by SEC, using Sepharose CL-2B columns made in-house
and eluted in 0.5 ml fractions. Soluble protein was measured by BCA
assay. Size and concentration of EVs was measured by tuneable
resistive pulse sensing (TRPS) using a qNano instrument. Transmis-
sion electron microscopy was used to validate size measurements
made by TRPS. EV protein was solubilized in TEAB lysis buffer0.1%
SDS for subsequent iTRAQ proteomics analysis. EV RNA was
extracted using either the Qiagen miRNeasy kit or Exiqon miRCURY
kit and quantified using a NanoDrop spectrophotometer. Results: The
in-house SEC columns successfully separated EVs from the soluble
protein in the conditioned medium. Peak EV elution was typically at
fraction 11, whilst significant amounts of soluble protein began
eluting from the column from fraction 14 onwards. EV protein yields
were typically 10 mg from purified EVs released by 2530 million
cells over 72 h. RNA from similar EV quantities purified by the
miRNeasy kit gave a comparatively low yield at 100250 ng, whereas
the miRCURY kit yielded 500 ng. Conclusion: Size exclusion
chromatography using columns fabricated in-house is a promising
alternative to other commonly used EV purification techniques. It
removes the need for specialist ultracentrifugation equipment and is
more cost effective than commercially available SEC alternatives.
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Purification of salivary extracellular vesicles by size exclusion
chromatography
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Background: Extracellular vesicles (EVs) are increasingly recognized as
a source of biomarkers for disease diagnosis and also as novel
therapeutic targets. They are nanoscale sized, membrane enclosed
vesicles that contain molecular cargo including nucleic acids and
proteins. They are produced by all cells of the body and are present
in biological fluids including saliva. Cancer cells produce increased
numbers of EVs with altered molecular cargo, and so EVs have
attracted much interest as a diagnostic tool for many cancers. We
have preliminary data showing that EVs are readily detectable in the
whole saliva of healthy volunteers and that they can be purified from
contaminating soluble factors by size exclusion chromatography
(SEC). Methods: EVs were purified from 3 to 5 ml of whole saliva
provided by healthy donors, using Sepharose CL-2B SEC columns
that were generated in-house. EVs were characterized by Tuneable
Resistive Pulse Sensing (TRPS) using a qNano instrument and by
transmission electron microscopy (TEM). Soluble protein was measured
using a micro-BCA kit. Results: EVs typically eluted in fractions 79 and
soluble protein eluted from fraction 10 onwards. TRPS revealed a
heterogeneous sized population of EVs with a mode diameter of 100
nm, which was confirmed by TEM. Conclusion: SEC appears to be a
suitable technique to separate salivary EVs from contaminating soluble
protein ready for downstream biomarker analysis.
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Purifying EV by size exclusion: give it a little longer
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Background: Extracellular vesicles are increasingly appreciated as
possessing functionally important biological activities. Size exclusion
is growing in popularity as a method of isolating pure and
functionally intact EVs. Here we present data concerning the effect
of column length on the efficacy of separation of EV-associated and
soluble protein. Methods: MDA-MB-231 cells were grown in a Corning
HYPERFlask in 550 ml DMEMFBS before serum-free conditioning
for 48 h. Cells and debris were removed with a 0.45 mm bottle-top
filter; 140 ml of media was concentrated to 9 ml using 100 kDa MWCO
Amicon Ultra-15 concentrators, aliquoted, and stored at 80 8C until
use; 10 mm diameter glass columns (Lenz Laborglas) were packed
with Sepharose CL-2B to depths of 9.5 and 28 cm (7.5 and 22.0 cm3,
respectively). They and qEV columns (iZON) were washed with 23
column volumes of fresh 0.22 mm-filtered PBS before each use.
Concentrated conditioned media (500 ml) was loaded onto
each column (n3); 0.5 ml fractions were collected, excluding the
void volume and those after 15.0 ml, for which 1 ml fractions were
collected. Protein concentration was determined using a micro-BCA
assay. Particle concentrations were measured on an LM10 Nanosight
(Malvern) (330s videos per sample, camera level 15, detection
threshold 10). Fractions were diluted to measure at B1010ˆ8
particles/ml. Results: Columns eluted both an initial low-concentra-
tion protein peak (B6 mg/ml and concurrent with particle elution)
and a later high-concentration peak. The resolution of these
peaks differed between columns. For the 9.5 cm column, 90% of
particles eluted between 2.0 and 5.0 ml, with the associated protein
appearing as a shoulder on a single continuous peak between 2.0 and
16.0 ml; 90% of particles eluted from the qEV column between 3.5
and 5.5 ml. The particle-associated and soluble protein peaks were
distinct but adjacent, between 3.55.5 and 5.514.0 ml respectively,
with fraction 5.5 containing 1 mg/ml protein; 90% of particles
eluted from the 28 cm column between 7.0 and 11.0 ml, with the
particle-associated protein peak between 7.0 and 9.5 ml. The major
protein peak eluted between 15.0 and 30.0 ml. The intermediate
fractions 10.014.0 contained B1 mg/ml protein. Conclusions:
The 28-cm column separated soluble and particle-associated protein
more effectively than the qEV and 9.5 cm columns. Increasing
the length of size exclusion columns improves separation of vesicles
Abstracts
Citation: Journal of Extracellular Vesicles 2016, 5: 30924 - http://dx.doi.org/10.3402/jev.v5.30924 15
from soluble protein contaminants with minor increases in proces-
sing time, allowing confident retrieval of the majority of the
EV peak without concerns of contamination in later EV-containing
fractions.
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Cells release subpopulations of exosomes with distinct
molecular and functional properties
Eduard Willms1, Henrik J. Johansson2, Imre Ma¨ger1, Yi Lee1,
K. Emelie M. Blomberg3, C.I. Edvard Smith3, Janne Lehtio¨2,
Samir EL Andaloussi1,3, Matthew J.A. Wood1 and
Pieter Vader1,4
1Department of Physiology, Anatomy and Genetics, Medical
Sciences Division, University of Oxford, Oxford, UK; 2Cancer Proteomics Mass
Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology,
Karolinska Institutet, Stockholm, Sweden; 3Department of Laboratory
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Background: Extracellular vesicles (EVs), including exosomes, are nano-
sized membrane vesicles involved in intercellular communication by
transferring biological information between cells. While numerous
cellular functions are attributed to exosomes in health and disease,
current dogma is that such vesicles are assumed to represent
a homogenous population of EVs. Here, we identify, characterize
and evaluate the biological effects of 2 distinct subpopulations of
exosomes released by different cell types. Methods: Exosome sub-
populations from various sources were isolated using differential
ultracentrifugation followed by sucrose gradient separation. Vesicles
were analysed by Nanosight analysis, western blotting and electron
microscopy. Exosome subpopulations from melanoma cells were
further characterized for protein and RNA composition using LC
MS/MS and Bioanalyzer analysis. Effects on gene expression in
recipient H5V endothelial cells were assessed using an Affymetrix
gene array. Results: Two distinct exosome subpopulations were
identified with different sedimentation and flotation characteristics.
Proteomic analysis allowed quantification of more than 2,000 proteins
(1% FDR), with a significant number of proteins unique to each of the
subpopulations. Subpopulations also differed in their RNA repertoires.
We further demonstrate that exosome subpopulations have differ-
ential effects on gene expression in recipient endothelial cells.
Conclusions: Cells release distinct subpopulations of exosomes that
differ in composition and biological effects on recipient cells. More
detailed analysis of exosome subpopulations will advance our
understanding of exosome biogenesis and functional effects, and
lead to a deeper insight into the biological basis for exosome-based
diagnostic and therapeutic development.
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Mie theory as a flow cytometer standardization tool for
extracellular vesicles
Joshua Aden Welsh, Judith A. Holloway, David C. Smith
and Nicola A. Englyst
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Background: Extracellular vesicle (EV) interest continues to increase.
Currently one of the main initiatives of the International Society of
Extracellular Vesicles, the International Society of Thrombosis and
Haemostasis and the International Society for Advancement of
Cytometry is the standardization of EV studies between groups. One
particular area of interest is the development of approximating EV size
between flow cytometry platforms, which are mainly utilized for
microvesicle analysis. Here we aim to show evidence of extracellular
vesicles being correlated with predicted light scatter using Mie theory.
Method: A total of 6 ml of blood was drawn into citrated tubes,
following a 2 ml discard. Tubes were centrifuged at 140 g for 20 min to
isolate platelet-rich plasma (PRP). Five microlitre of PRP was added to
200 ml HEPES buffered saline (HBS)2 mM CaCl2 to stimulate
platelet activation. Samples were incubated at 378C before centrifuga-
tion at 1,500 g twice. Supernatants were stored at 808C. Super-
natants were thawed at 378C. 100 ml of supernatant was added to 2 ml
500 mM glycine, N-[2-[(acetyloxy)methoxy]-2-oxoethyl]-N-[4-[[[3’,6’-
bis(acetyloxy)-2’,7’-difluoro-3-oxospiro [isobenzofuran-1(3H),9’-[9H]
xanthen]-5-yl]carbonyl]amino]-2-[2-[2-[bis[2-[(acetyloxy)methoxy]-2-
oxoethyl]amino]phenoxy]ethoxy]phenyl]-, (acetyloxy)methyl ester
(BAPTA-1-AM) and spun at 20,000 g30 min. Supernatants were
discarded and 100 ml HBS2 mM CaCl2 was used to resuspend the
microvesicle pellet. Five microlitre of 25 mg/ml Annexin V PerCP-Cy5.5
was added and incubated on ice for 20 min; 2 ml of 200 mM violet
ratiometric asymmetry probe (VRD) was added and incubated for
5 min. Samples were analysed on a FACSAria and custom Attune NxT,
as well as confocal microscopy. Results: Confocal images show that
BATPA-1-AM staining was successful. The sample contains particles
B1 mm, likely large EVs and also particles that are 1 mm likely to be
apoptotic bodies, lipoproteins or residual platelets. The FACSAria
showed that EVs had a stain index of 1.69 for BAPTA-1-AM, 1.31 for
Annexin V and 1.75 for VRD. The population stained with these dyes
were 13.3, 8.8 and 33.9%, respectively. The Attune NxT particles had
a stain index of 0.07 for BAPTA-1-AM, 0.29 for Annexin V and 0.30
for VRD. The population stained with these dyes were 1.87, 1.99 and
34.4%, respectively. Discussion: While VRD had a consistent staining
efficacy between flow cytometers, due to its universal applicability,
BAPTA-1-AM and Annexin V had very different results on both
cytometry platforms. It is not until the true resolution of the platforms
is taken into account using Mie theory that a consistent view can be
seen. That larger particles 1,000 nm are staining for BAPTA-1-AM
only, with the majority of annexin V positive particles (B1,000 nm) are
visible on the custom Attune NxT.
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